Related Experiment Videos
Can cataract be prevented?
1Nuffield Laboratory of Ophthalmology, University of Oxford, UK.
Abstract:
The feasibility of preventing cataract by elimination of risk factors or by anti-cataract therapy is reviewed. Elimination of the major risk factors in Western countries would be difficult, although it has potential in the developing world. Various approaches to drug therapy have been made but ran into problems. The development of aldose reductase inhibitors received by far the greatest financial support but problems with toxicity were rapidly followed by the collapse of the original hypothesis. The case of aspirin, paracetamol and ibuprofen built up more slowly with no encouragement from the pharmaceutical industry. Positive results have been achieved in vitro, and in the prevention of diabetic cataract in rats, as well as the identification of an association with a protective effect against cataract in human patients. A clinical trial of these compounds is required. Other anti-cataract agents are also being investigated.
Insights
Preventing cataracts through risk factor elimination is challenging globally. However, non-steroidal anti-inflammatory drugs show promise in preventing cataracts, warranting further clinical trials.
Area of Science:
- Ophthalmology
- Pharmacology
- Preventive Medicine
Background:
- Cataract prevention strategies include risk factor elimination and anti-cataract therapies.
- Major risk factor elimination presents challenges, particularly in Western countries, but holds potential in developing nations.
- Past drug therapy approaches, including aldose reductase inhibitors, faced significant hurdles like toxicity and invalidated hypotheses.
Purpose of the Study:
- To review the feasibility of cataract prevention via risk factor modification and anti-cataract drug therapy.
- To assess the efficacy and challenges associated with various anti-cataract therapeutic approaches.
- To highlight promising new avenues for cataract prevention, including non-steroidal anti-inflammatory drugs.
Main Methods:
- Review of existing literature on cataract prevention strategies.
- Analysis of the development and outcomes of aldose reductase inhibitors.
- Examination of in vitro, animal model, and human association studies for non-steroidal anti-inflammatory drugs.
Main Results:
- Eliminating major cataract risk factors is difficult in Western countries but feasible in developing regions.
- Aldose reductase inhibitors faced toxicity issues and their initial hypothesis was disproven.
- Non-steroidal anti-inflammatory drugs (aspirin, paracetamol, ibuprofen) demonstrated positive in vitro results, prevented diabetic cataract in rats, and showed a protective association in human patients.
Conclusions:
- While risk factor elimination has limitations, drug therapies offer potential for cataract prevention.
- Non-steroidal anti-inflammatory drugs show significant promise and require further investigation through clinical trials.
- Continued research into novel anti-cataract agents is essential for advancing prevention strategies.